[CytoReason in Reuters] Nvidia, Pfizer lead $80 mln funding for Israeli medical AI tech firm CytoReason
JERUSALEM, July 17 (Reuters) – Israel’s CytoReason, which uses AI to develop disease models, said on Wednesday it had raised $80 million in a private funding round. Read...
Read More